The potential of a newly developed transgenic mouse liver platform in the investigation of hepatocellular carcinoma and perspectives on PARP inhibitor-based therapy

Read full text
Authors: Kopasz Anna Georgina
Cited by: 0

Fields of Study & Subjects

PARP inhibition in cancer therapy Hepatocellular Carcinoma Treatment and Prognosis Cancer Research and Treatments

Publication details

Journal / source
SZTE Repository of Dissertations (University of Szeged)
Publication date
31 March 2026
Language
EN
Document type
Thesis